Stay updated on KTE-C19 + Atezolizumab in DLBCL Clinical Trial

Sign up to get notified when there's something new on the KTE-C19 + Atezolizumab in DLBCL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the KTE-C19 + Atezolizumab in DLBCL Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    No additions or deletions detected on the Study Details page for NCT02926833; the content and structure appear the same across the screenshots.
    Difference
    0.4%
    Check dated 2025-11-03T21:33:22.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    33 days ago
    Change Detected
    Summary
    - Page now includes a government operating status notice and directs to official sources for updates. - Version updated from v3.1.0 to v3.2.0. - Adds a new resource topic: Malignant lymphoma, large B-cell, diffuse.
    Difference
    3%
    Check dated 2025-10-06T06:57:40.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    Upgrade applied: version updated from v3.0.2 to v3.1.0. No other substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T03:47:40.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2 (new release). The 'Back to Top' link was removed as a minor UI cleanup.
    Difference
    0.1%
    Check dated 2025-09-14T21:25:43.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-09-07T17:26:27.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as new drug information for several compounds related to hemic and lymphatic diseases. Notably, previous drug information for Atezolizumab and Axicabtagene Ciloleucel has been removed.
    Difference
    4%
    Check dated 2025-08-31T12:13:18.000Z thumbnail image

Stay in the know with updates to KTE-C19 + Atezolizumab in DLBCL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the KTE-C19 + Atezolizumab in DLBCL Clinical Trial page.